# Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD

> **NCT03131050** · PHASE4 · COMPLETED · sponsor: **Capital Medical University** · enrollment: 66 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Scopolamine
- **DRUG:** Escitalopram
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03131050
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-15
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-03-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131050, "Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03131050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*